XYRA Announces FDA Label Guidance for Managing Atrial Fibrillation with Budiodarone and Wearable Monitoring Devices

CardioSight, Inc. Appoints New CEO

LeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024

CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024

VS Enrolls First Patient in U.S. Pivotal Intravascular Lithotripsy Study POWER PAD II IDE trial will evaluate safety and efficacy of the Pulse IVL™ system in patients with severely calcified peripheral arterial disease

AI Ethics in Personalized Medicine: Key Insights for Doctors

AI's Real-World Impact: Clinical Decision Support

AI-Repurposed Drugs: Essential Considerations for Physicians

Infographic: Cognitive Tests for Older Docs?

Does Mast Cell Activation Syndrome Underlie Multiple Ills?